These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7966701)

  • 41. Evaluation of the effects of temporary covered nitinol stent placement in the prostatic urethra: short-term study in the canine model.
    Crisóstomo V; Song HY; Maynar M; Sun F; Soria F; Lima JR; Yoon CJ; Usón-Gargallo J
    Cardiovasc Intervent Radiol; 2007; 30(4):731-7. PubMed ID: 17436035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin blocks binding of photosensitizer SnET2 into human serum albumin: implications for photodynamic therapy.
    Skrzypczak-Jankun E; Borbulevych OY; Melillo A; Keck R; Soriano-Garcia M; Aniola J; Niedre M; Lilge L; Selman SH; Jankun J
    Int J Mol Med; 2005 May; 15(5):777-83. PubMed ID: 15806298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Healing response of the canine prostate to Nd:YAG laser radiation.
    Pow-Sang M; Orihuela E; Motamedi M; Torres J; Adesokan A; Cowan D; Warren MM
    Prostate; 1996 May; 28(5):287-94. PubMed ID: 8610054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The bystander effect in photodynamic inactivation of cells.
    Dahle J; Bagdonas S; Kaalhus O; Olsen G; Steen HB; Moan J
    Biochim Biophys Acta; 2000 Jul; 1475(3):273-80. PubMed ID: 10913826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate.
    Chevalier S; Anidjar M; Scarlata E; Hamel L; Scherz A; Ficheux H; Borenstein N; Fiette L; Elhilali M
    J Urol; 2011 Jul; 186(1):302-9. PubMed ID: 21600602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laser dosimetry studies in the prostate.
    Chen Q; Hetzel FW
    J Clin Laser Med Surg; 1998 Feb; 16(1):9-12. PubMed ID: 9728124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of lipoproteins in the distribution of tin etiopurpurin (SnET2) in the tumor-bearing rat.
    Kessel D; Garbo GM; Hampton J
    Photochem Photobiol; 1993 Feb; 57(2):298-301. PubMed ID: 8451293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia.
    Schulman CC; Zlotta AR
    Prog Clin Biol Res; 1994; 386():479-86. PubMed ID: 7528418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectroscopic studies of tin ethyl etiopurpurin in homogeneous and heterogeneous systems.
    Sekher P; Garbo GM
    J Photochem Photobiol B; 1993 Oct; 20(2-3):117-25. PubMed ID: 8271113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photodynamic therapy for corneal neovascularization.
    Primbs GB; Casey R; Wamser K; Snyder WJ; Crean DH
    Ophthalmic Surg Lasers; 1998 Oct; 29(10):832-8. PubMed ID: 9793949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A radiofrequency method of thermal tissue ablation for benign prostatic hyperplasia.
    Bhanot SM; Grigor KM; Hargreave TB; Chisholm GD
    Urology; 1995 Mar; 45(3):427-33; discussion 433-4. PubMed ID: 7533454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Light-microscopic stereologic analysis of spontaneous and steroid-induced canine prostatic hyperplasia.
    Bartsch G; Bruengger A; de Klerk DP; Coffey DS; Rohr HP
    J Urol; 1987 Mar; 137(3):552-8. PubMed ID: 2434668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transurethral prostate ablation using saline-liquid electrode introduced via flexible cystoscope.
    Hoey MF; Dixon CM; Paul S
    J Endourol; 1998 Oct; 12(5):461-8. PubMed ID: 9847071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostatic cryotherapy: ultrasonographic and pathologic correlation in the canine model.
    Littrup PJ; Mody A; Sparschu R; Prchevski P; Montie J; Zingas AP; Grignon D
    Urology; 1994 Aug; 44(2):175-83; discussion 183-4. PubMed ID: 8048191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histotripsy of the Prostate in a Canine Model: Characterization of Post-Therapy Inflammation and Fibrosis.
    Darnell SE; Hall TL; Tomlins SA; Cheng X; Ives KA; Roberts WW
    J Endourol; 2015 Jul; 29(7):810-5. PubMed ID: 25566880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benign prostatic hyperplasia: US-guided transrectal urethral enlargement with radio frequency--initial results in a canine model.
    Goldberg SN; Hahn PF; McGovern FJ; Fogle RM; Mueller PR; Gazelle GS
    Radiology; 1998 Aug; 208(2):491-8. PubMed ID: 9680581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-intensity focused ultrasound in the treatment of prostatic tissue.
    Bihrle R; Foster RS; Sanghvi NT; Fry FJ; Donohue JP
    Urology; 1994 Feb; 43(2 Suppl):21-6. PubMed ID: 7509533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer.
    Mang TS; Allison R; Hewson G; Snider W; Moskowitz R
    Cancer J Sci Am; 1998; 4(6):378-84. PubMed ID: 9853137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.